Bpifrance led a €61m Series C round in CorWave, a fast-paced medical device company that develops innovative heart-assist pumps to bring a reliable and sustainable solution to heart failure. "We were particularly impressed by CorWave's value proposition. Its wave membrane heart pump will provide a new solution to a major public health issue: heart failure. Supporting CorWave's industrialization project is fully in line with the SPI fund's raison d'être, being a partner to industrial start-ups manufacturing high value-added products in France," Magali Joëssel, Bpi Managing Director.